NCT00919061: Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy |
|
|
| Completed | 2 | 39 | US | Gemcitabine, Cisplatin, Sorafenib | Memorial Sloan Kettering Cancer Center, Bayer | Extrahepatic Bile Duct Cancer, Gallbladder Cancer | 03/14 | 03/14 | | |
